Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cervical ripening using misoprostol before hysteroscopy].

A Agostini1, K Blanc, I Ronda

  • 1Service de gynécologie-obstétrique, secteur B, hôpital La Conception, 147, boulevard Baille, 13385 Marseille cedex 05, France. aagostini@mail.ap-hm.fr

Gynecologie, Obstetrique & Fertilite
|January 18, 2006
PubMed
Summary

Cervical ripening with misoprostol may reduce cervical tears during operative hysteroscopy but offers limited benefit for office hysteroscopy. Further research is needed to determine optimal misoprostol dosage and administration for hysteroscopy procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Appropriateness of treatments for postpartum and post-abortion uterine vascular anomalies.

European journal of obstetrics, gynecology, and reproductive biology·2025
Same author

Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer.

Scientific reports·2024
Same author

Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance.

Cell death & disease·2024
Same author

Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation.

Cancer genetics·2024
Same author

The role of progestin subdermal implant in the management of adenomyosis: a systematic review.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2024
Same author

The Impact of Oxidative Stress on Pregnancy. The Neglected Role of Alcohol Misuse.

La Clinica terapeutica·2024

Area of Science:

  • Gynecology
  • Surgical Procedures
  • Pharmacology

Context:

  • Hysteroscopy, an endoscopic examination of the uterine cavity, is a common gynecological procedure.
  • Cervical preparation, or ripening, is often employed to facilitate hysteroscopy, particularly in cases of cervical stenosis or in postmenopausal women.
  • Misoprostol, a prostaglandin E1 analog, is frequently used for cervical ripening.

Purpose:

  • To systematically review the existing literature on the efficacy and safety of using misoprostol for cervical ripening prior to office or operative hysteroscopy.
  • To evaluate whether misoprostol confers benefits in terms of ease of procedure, patient comfort, and reduction of complications such as cervical trauma.

Summary:

  • A review of ten studies indicates that misoprostol may not be beneficial for office hysteroscopy, especially with minihysteroscopes.

Related Experiment Videos

  • Its utility in menopausal women undergoing traditional office hysteroscopy remains debatable.
  • Misoprostol appears to reduce the risk of cervical tears during operative hysteroscopy, although this benefit was not universally observed across all studies.
  • Insufficient data exist to establish optimal misoprostol dosage, timing, or mode of administration, though vaginal administration is suggested as preferable.

    • Impact:

    • Findings suggest that misoprostol's role in pre-hysteroscopy cervical preparation may be procedure-dependent, potentially more beneficial in operative settings than in routine office procedures.
    • Highlights the need for further high-quality research to clarify optimal protocols for misoprostol use in hysteroscopy.
    • Informs clinical decision-making regarding the use of pharmacological cervical ripening agents before hysteroscopic interventions.